| Drug Name: | Bethanidine (55-73-2) |
|---|---|
| PubChem ID: | 2368 |
| SMILES: | CNC(=NC)NCC1=CC=CC=C1 |
| InchiKey: | NIVZHWNOUVJHKV-UHFFFAOYSA-N |
| Therapeutic Category: | Adrenergic Agents, Antihypertensive Agents, Autonomic Agents, Cardiovascular Agents, Neurotransmitter Agents, Peripheral Nervous System Agents, Sympatholytics |
| Molecular Weight (dalton) | : | 177.251 |
| LogP | : | 0.9814 |
| Ring Count | : | 1 |
| Hydrogen Bond Acceptor Count | : | 1 |
| Hydrogen Bond Donor Count | : | 2 |
| Total Polar Surface Area | : | 36.42 |
This panel provides information on interacting drugs and their ADRs along with references
| Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
|---|
This panel provides drug-protein interaction and their ADRs along with references
| Toxicity | Interacting Protein | Mechanism | Reference |
|---|
This panel provides drug-food interactions and their ADRs along with references
| Food | Toxicity | Reference |
|---|
This panel provides information on metabolites and their ADRs along with references
| Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
|---|
This panel provides information on drug category